SAIC-Frederick

About SAIC Frederick

SAIC-Frederick, Inc. develops and applies advanced technologies to accelerate the delivery of new treatments to patients with cancer and AIDS.

The company is a wholly owned subsidiary of Science Applications International Corporation and operates exclusively under a single, long-term contract to the Frederick National Laboratory for Cancer Research, part of the U.S. National Institutes of Health.

SAIC-Frederick's staff of scientific, technical, and support professionals conducts basic and applied research in cancer and AIDS, and maintains a full suite of advanced technologies in areas such as nanotechnology, genomics, and biomedical imaging.

The Company

• Operates the federal government's vaccine and pharmaceutical manufacturing facilities, one for Frederick National Laboratory for Cancer Research and the other for the National Institute of Allergy and Infectious Diseases
• Operates the high-performance Advanced Biomedical Computing Center
• Supports more than 300 clinical trials for patients in the United States and around the world
• Develops new standards for using nanotechnology in safe and effective treatments for cancer and other diseases

SAIC-Frederick manages a pilot program of 30 community hospitals in 22 states that is exploring the best way to bring the most advanced, research-driven cancer care to patients in small-town, rural, and inner-city communities where they live, and to involve more patients in cancer research.